2016
DOI: 10.1016/j.phrs.2016.01.031
|View full text |Cite
|
Sign up to set email alerts
|

Recent updates on GPCR biased agonism

Abstract: G protein-coupled receptors (GPCRs) are the most important targets for drug discovery and not surprisingly ∼40% of all drugs currently in the market act on these receptors. Currently, one of the most active areas in GPCRs signaling is biased agonism, a phenomenon that occurs when a given ligand is able to preferentially activate one (or some) of the possible signaling pathways. In this review, we highlight the most recent findings about biased agonism, including an extension of this concept to intracellular si… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
67
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 82 publications
(68 citation statements)
references
References 91 publications
1
67
0
Order By: Relevance
“…GPCRs can use different G proteins when binding different ligands or in the presence of allosteric modulators, termed biased agonism [15]. To address whether OGR1 might couple to cyclic AMP (cAMP) signaling pathways in a substrate-stiffness-dependent manner, hOGR1-HEK cells were seeded on high-and low-stiffness substrate.…”
Section: Ogr1 Does Not Display Stiffness-dependent G Protein Couplingmentioning
confidence: 99%
“…GPCRs can use different G proteins when binding different ligands or in the presence of allosteric modulators, termed biased agonism [15]. To address whether OGR1 might couple to cyclic AMP (cAMP) signaling pathways in a substrate-stiffness-dependent manner, hOGR1-HEK cells were seeded on high-and low-stiffness substrate.…”
Section: Ogr1 Does Not Display Stiffness-dependent G Protein Couplingmentioning
confidence: 99%
“…A critical assumption is that the heterogeneity of active receptor conformations spontaneously exists and the ligand stabilizes a particular conformational subset that fails to evoke some of the responses but may stimulate other signaling events of the receptor to which it binds (Kenakin, 2004;Rajagopal et al, 2010). This process of "stimulus trafficking" has also been referred to as biased agonism or functional selectivity, and it explains why a ligand causes differential activation of only some of the signaling pathways associated with a specific receptor (Pupo et al, 2016).…”
Section: Biased Signaling At H 1 and H 2 Histamine Receptorsmentioning
confidence: 99%
“…6). However, the subsequent steps in the signaling cascade are continuously being explored; for example, biased agonism [41], molecular dynamics through allosteric nanobodies [42], and possible short‐lived intermediates [43] are among those steps.…”
Section: Discussionmentioning
confidence: 99%